Health Tidings ResearchFDA Issues Third CRL for Outlook Therapeutics’ ONS-5010/LYTENAVA in W... FDA Issues Third CRL for Outlook Therapeutics’ ONS-5010/LYTENAVA in W... Read Post »
Health Tidings ResearchCorcept Therapeutics Receives FDA Complete Response Letter for Relacorilant... Corcept Therapeutics Receives FDA Complete Response Letter for Relacorilant... Read Post »
Health TidingsNovo Nordisk Wins Final Patent Ruling on Semaglutide in China Novo Nordisk Wins Final Patent Ruling on Semaglutide in China Read Post »
Health Tidings ResearchGenmab Halts Clinical Development of Acasunlimab After Portfolio Review, Sh... Genmab Halts Clinical Development of Acasunlimab After Portfolio Review, Sh... Read Post »
Health TidingsEnvafolimab Granted FDA Orphan Drug Designation for Gastric and GEJ Cancer:... Envafolimab Granted FDA Orphan Drug Designation for Gastric and GEJ Cancer:... Read Post »
Health TidingsFDA Issues CRL for Sanofi’s Tolebrutinib in Non-Relapsing Secondary Progr... FDA Issues CRL for Sanofi’s Tolebrutinib in Non-Relapsing Secondary Progr... Read Post »
Health TidingsIpsen licenses SIM0613 ADC from Simcere Zaiming, targeting Phase I in 2026 Ipsen licenses SIM0613 ADC from Simcere Zaiming, targeting Phase I in 2026 Read Post »
Health TidingsJ&J Supports HRS Registry to Advance PFA Evidence in AFib J&J Supports HRS Registry to Advance PFA Evidence in AFib Read Post »
Health Tidings ResearchFDA Grants Advanced Manufacturing Technology Designation to Astellas’ Mah... FDA Grants Advanced Manufacturing Technology Designation to Astellas’ Mah... Read Post »
Health Tidings ResearchBlueRock Therapeutics’ Bemdaneprocel Earns Pioneering Regenerative Medica... BlueRock Therapeutics’ Bemdaneprocel Earns Pioneering Regenerative Medica... Read Post »
Health Tidings ResearchNo Patient Identifiers Needed: FDA Removes a Key Barrier to Using Real-Worl... No Patient Identifiers Needed: FDA Removes a Key Barrier to Using Real-Worl... Read Post »
Health Tidings ResearchFDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... FDA Moves Toward Real-World Evaluation of Digital Devices With TEMPO Progra... Read Post »
Health Tidings ResearchAbbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Abbott Launches Two New Ensure® Max Protein Shakes: 42g Protein and 2-in-1... Read Post »
Health Tidings ResearchEli Lilly Lowers Single-Dose Zepbound Vial Prices Eli Lilly Lowers Single-Dose Zepbound Vial Prices Read Post »
Clinical Trials Health TidingsAlexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Alexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Read Post »
Health Tidings ResearchEli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Eli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Read Post »
Health TidingsFDA Approves CAPLYTA® (Lumateperone) as Adjunctive Therapy for Major Depre... FDA Approves CAPLYTA® (Lumateperone) as Adjunctive Therapy for Major Depre... Read Post »
Health Tidings ResearchNovo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Novo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Read Post »
Health TidingsFDA Rejects Biohaven’s Vyglxia for Spinocerebellar Ataxia Citing External... FDA Rejects Biohaven’s Vyglxia for Spinocerebellar Ataxia Citing External... Read Post »
Health TidingsDupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Dupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Read Post »
Health TidingsYeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Yeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Read Post »
Health TidingsFDA Issues Complete Response Letter to Regeneron for Eylea HD Prefilled-Syr... FDA Issues Complete Response Letter to Regeneron for Eylea HD Prefilled-Syr... Read Post »
Health TidingsFDA Issues Complete Response Letter to Sydnexis for SYD-101 Pediatric Myopi... FDA Issues Complete Response Letter to Sydnexis for SYD-101 Pediatric Myopi... Read Post »
Health TidingsNeutrogena Makeup Remover Towelettes Recall 2025: What You Need to Know Abo... Neutrogena Makeup Remover Towelettes Recall 2025: What You Need to Know Abo... Read Post »
Health TidingsFDA Issues Complete Response Letter to Xbrane Biopharma for Ranibizumab Bio... FDA Issues Complete Response Letter to Xbrane Biopharma for Ranibizumab Bio... Read Post »
Health Tidings New Drug ApprovalMounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Mounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Read Post »
Health TidingsFDA Expands Recall of Cinnamon over Dangerous Lead Levels FDA Expands Recall of Cinnamon over Dangerous Lead Levels Read Post »
Health TidingsFDA Issues Complete Response Letter to Xspray Pharma’s Dasynoc Due to GMP... FDA Issues Complete Response Letter to Xspray Pharma’s Dasynoc Due to GMP... Read Post »
Clinical Trials Health TidingsWHO Launches Global Clinical Trials Forum to Boost Worldwide Health Researc... WHO Launches Global Clinical Trials Forum to Boost Worldwide Health Researc... Read Post »
Health TidingsRising Cases of New COVID Variants Stratus and Nimbus in USA and UK: What Y... Rising Cases of New COVID Variants Stratus and Nimbus in USA and UK: What Y... Read Post »
Health TidingsIndia Bans Toxic Cough Syrup: State-Wise Actions after Children Deaths India Bans Toxic Cough Syrup: State-Wise Actions after Children Deaths Read Post »
Drugs Safety Alert Health TidingsRising Cough Syrup Linked Deaths in India Put Children’s Safety in Spotli... Rising Cough Syrup Linked Deaths in India Put Children’s Safety in Spotli... Read Post »
Health TidingsFDA Issues Complete Response Letter for Higher Dose of Biogen’s SMA Drug ... FDA Issues Complete Response Letter for Higher Dose of Biogen’s SMA Drug ... Read Post »
Health Tidings ResearchIndian State of Kerala Reports Brain-Eating Amoeba Cases: A rare infection ... Indian State of Kerala Reports Brain-Eating Amoeba Cases: A rare infection ... Read Post »
Health Tidings ResearchFDA to Take Stricter Action on Misleading Drug Ads, Says Commissioner FDA to Take Stricter Action on Misleading Drug Ads, Says Commissioner Read Post »
Health TidingsFDA Issues Draft Guidance: Development of Non-Opioid Analgesics for Chronic... FDA Issues Draft Guidance: Development of Non-Opioid Analgesics for Chronic... Read Post »
Health TidingsFDA Expands Vonvendi Use for von Willebrand Disease FDA Expands Vonvendi Use for von Willebrand Disease Read Post »
Health TidingsWHO’s 2025 Essential Medicines List Update: New Cancer, Diabetes & W... WHO’s 2025 Essential Medicines List Update: New Cancer, Diabetes & W... Read Post »
Health Tidings ResearchNew Ebola outbreak in Kasai province of DR Congo-WHO Confirmed New Ebola outbreak in Kasai province of DR Congo-WHO Confirmed Read Post »
Health TidingsFDA to Publish Drugs and Biologicals Rejection Letters (CRL) in Real Time: ... FDA to Publish Drugs and Biologicals Rejection Letters (CRL) in Real Time: ... Read Post »
Health TidingsEngland Moves to Ban High-Caffeine Energy Drinks for Under-16s England Moves to Ban High-Caffeine Energy Drinks for Under-16s Read Post »
Health Tidings“Pune Couple’s Death after Liver Transplant Raises Safety Questions” “Pune Couple’s Death after Liver Transplant Raises Safety Questions” Read Post »
Health TidingsFast Fade and Faster Return: What’s Behind Dr.Vinay Prasad’s Exit and R... Fast Fade and Faster Return: What’s Behind Dr.Vinay Prasad’s Exit and R... Read Post »
Health Tidings Policy & AcquisitionsTopline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual ... Topline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual ... Read Post »
Health TidingsCDSCO Issues Advisory on Flushing 17 Expired Drugs: A Crucial Step for Publ... CDSCO Issues Advisory on Flushing 17 Expired Drugs: A Crucial Step for Publ... Read Post »
Health TidingsAlphabet’s Inc. subsidiary Isomorphic Labs Initiates Human Trials of Firs... Alphabet’s Inc. subsidiary Isomorphic Labs Initiates Human Trials of Firs... Read Post »
Disease & Drugs Health TidingsCan the Weight Loss Indication of Semaglutide and Tirzepatide Be Revoked in... Can the Weight Loss Indication of Semaglutide and Tirzepatide Be Revoked in... Read Post »
Disease & Drugs Health TidingsWegovy vs. Mounjaro: A Head-On Comparison at the Dawn of Wegovy’s Launch ... Wegovy vs. Mounjaro: A Head-On Comparison at the Dawn of Wegovy’s Launch ... Read Post »
Health TidingsRising Threat: the Latest Aspergillus fumigatus Outbreak in the U.S. and Gl... Rising Threat: the Latest Aspergillus fumigatus Outbreak in the U.S. and Gl... Read Post »
Health Tidings“UK’s Martha’s Rule: A Mother’s Fight That Sparked a National R... “UK’s Martha’s Rule: A Mother’s Fight That Sparked a National R... Read Post »
